Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Antibiotic Eye Drops Recalled
03/20/2019
A Class II recall is active for a prescription aminoglycoside antibiotic used to treat blepharitis, conjunctivitis, and other bacterial infections of and around the eyes.
A Class II recall is active for a prescription aminoglycoside antibiotic used to treat blepharitis, conjunctivitis, and other bacterial infections of and around the eyes.
A Class II recall is active for...
03/20/2019
Pharmacy Learning Network
News
Hypertension Drug Recalled
03/20/2019
The FDA is recalling a prescription drug used in the treatment of high blood pressure.
The FDA is recalling a prescription drug used in the treatment of high blood pressure.
The FDA is recalling a...
03/20/2019
Pharmacy Learning Network
News
FDA Will Not Modify Names of Already Licensed Biologics
03/20/2019
“As the FDA continues to apply this policy, we expect that a steadily increasing proportion of licensed biological products, including originator products, will have nonproprietary names that include four-letter suffixes,” Dr. Gottlieb said.
“As the FDA continues to apply this policy, we expect that a steadily increasing proportion of licensed biological products, including originator products, will have nonproprietary names that include four-letter suffixes,” Dr. Gottlieb said.
“As the FDA continues to apply...
03/20/2019
Pharmacy Learning Network

Advertisement

News
FDA Sends Warning Letter to Company Marketing Unapproved Chronic Pain Treatments
03/19/2019
The FDA has posted a warning letter for a company that is illegally marketing a variety of unapproved products that claim to treat addiction and chronic pain.
The FDA has posted a warning letter for a company that is illegally marketing a variety of unapproved products that claim to treat addiction and chronic pain.
The FDA has posted a warning...
03/19/2019
Pharmacy Learning Network
News
Chronic Pain: Does Moderate Alcohol Consumption Decrease Severity?
03/18/2019
Researchers sought to better understand the role moderate alcohol consumption played for patients with chronic pain.
Researchers sought to better understand the role moderate alcohol consumption played for patients with chronic pain.
Researchers sought to better...
03/18/2019
Pharmacy Learning Network
News
Updated Guidelines on Early Allergy Prevention Released
03/18/2019
The American Academy of Pediatrics has released new guidelines on the prevention of atopic diseases in infants and children. Specifically, the recommendations focus on maternal and early infant diet.
The American Academy of Pediatrics has released new guidelines on the prevention of atopic diseases in infants and children. Specifically, the recommendations focus on maternal and early infant diet.
The American Academy of...
03/18/2019
Pharmacy Learning Network

Advertisement

News
New Guidelines Discourage Aspirin Use for Primary ASCVD Prevention
03/18/2019
The American College of Cardiology/American Heart Association recommend that aspirin should be used infrequently in the routine primary prevention of atherosclerotic cardiovascular disease.
The American College of Cardiology/American Heart Association recommend that aspirin should be used infrequently in the routine primary prevention of atherosclerotic cardiovascular disease.
The American College of...
03/18/2019
Pharmacy Learning Network
News
Ophthalmic Injection Recalled
03/14/2019
A recall is active for a prescription antibiotic used to prevent surgical infection when administered intraocularly at the end of a procedure.
A recall is active for a prescription antibiotic used to prevent surgical infection when administered intraocularly at the end of a procedure.
A recall is active for a...
03/14/2019
Pharmacy Learning Network
News
Recall: Birth Control Pills Packaged Out of Sequence
03/14/2019
Prescription hormonal contraceptives used to prevent pregnancy and treat premenstrual dysphoric disorder and acne are being recalled.
Prescription hormonal contraceptives used to prevent pregnancy and treat premenstrual dysphoric disorder and acne are being recalled.
Prescription hormonal...
03/14/2019
Pharmacy Learning Network

Advertisement

News
Prostate Drug Recalled
03/14/2019
A recall is active for a prescription alpha-blocker used to treat benign prostatic hyperplasia.
A recall is active for a prescription alpha-blocker used to treat benign prostatic hyperplasia.
A recall is active for a...
03/14/2019
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use